A systematic review of salvage therapy to patients with metastatic colorectal cancer previously treated with fluorouracil, oxaliplatin and irinotecan +/- targeted therapy.

@article{Nielsen2014ASR,
  title={A systematic review of salvage therapy to patients with metastatic colorectal cancer previously treated with fluorouracil, oxaliplatin and irinotecan +/- targeted therapy.},
  author={Dorte Lisbet Nielsen and Jesper Andreas Palshof and Finn Ole Larsen and Benny Vittrup Jensen and Per Pfeiffer},
  journal={Cancer treatment reviews},
  year={2014},
  volume={40 6},
  pages={701-15}
}
UNLABELLED Oxaliplatin, irinotecan and 5-fluorouracil in combination with or without targeted therapies are well-documented treatment options for first- and second-line treatments of metastatic colorectal cancer. However, there are much less data on the beneficial effect on systemic therapy in the third-line setting. We therefore performed a systematic review of the current literature on third or later lines of treatment to patients with metastatic colorectal cancer after the use of approved… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Beyond second-line therapy in patients with metastatic colorectal cancer: a systematic review

Annals of oncology : official journal of the European Society for Medical Oncology • 2018
View 10 Excerpts
Highly Influenced

Influence of PLGA and PLGA-PEG on the dissolution profile of oxaliplatin

E Pereira, Renata Cerruti, +6 authors Fernando Gomes de Souza Júnior
2016
View 1 Excerpt

Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland • 2016

Similar Papers

Loading similar papers…